Skip to main content

Products | ioCells

Deterministically programmed human iPSC-derived cells for research and drug discovery

Discover ioCells
iocells_vial_radial_0

Cell coding platform

Our platform has the ability to create any human cell type and to manufacture it at scale with precision and consistency. 

Explore our platform
bit.bio–cell_coding_platform_diagram–V28-outlinedTextWebs bit.bio–cell_coding_platform_diagram–V28-outlinedTextMobile

Services | CRISPR screening 

Access CRISPR-based functional genomics screening in human cells with our suite of customisable service options and an expert-led path from concept to results.

Learn more

Latest news

bit.bio brings human cardiomyocytes to its drug discovery portfolio through partnership with myriamed
News

bit.bio brings human cardiomyocytes to its drug discovery portfolio through partnership with myriamed

23.09.2026 Published by bit.bio
bit.bio announces CRISPR screening service and appoints Chief Technology Officer to lead next phase of growth
Article

bit.bio announces CRISPR screening service and appoints Chief Technology Officer to lead next phase of growth

13.08.2026 Published by bit.bio
The coded cells redefining research and drug discovery
Article

The coded cells redefining research and drug discovery

21.07.2026 Published by bit.bio
Interview with Lord David Prior on the future of healthcare and drug discovery
Article

Interview with Lord David Prior on the future of healthcare and drug discovery

17.07.2026 Published by bit.bio